Are you struggling to find the right treatment for your hypothyroid patients?

Are you dealing with shortages and recalls that bring you back to square one?

Hypothyroid pharmacotherapy has a long history of challenges and as any physician or provider can attest to – there is no single bulls-eye treatment solution. The individual differences in response to thyroid medications are vast, the supply-chain is troubling, and patient frustration is evident. In this webinar, we will explore alternative solutions for your patients that are unable to reach their best selves on traditional levothyroxine monotherapy. We will discuss emerging preferences and evidence in support of not only combination levothyroxine (L-T4) and liothyronine (L-T3) treatment, but also preference and evidence in support of natural thyroid extract. In discussing options for natural thyroid extract, we will address challenges with commercially available forms, including quality, recalls, availability, allergen ingredients, and more. With the evidence on challenges mounting, we will present solutions and alternative options that all prescribers should have in their back pocket.

Led by pharmacotherapeutic expert in hormone therapy and facilitator of globally recognized continuing education program on personalizing hormone therapy – Dr. Ken Speidel – this webinar will:

• Explore opportunities for personalization through pharmaceutical compounding.
• Drive evidence that has you thinking outside the box.
• Present a case for natural thyroid extract.
• Introduce what a consistent and quality supply can look like.
• Create an opportunity for improved patient care.

KEN SPEIDEL, BS Pharm, PharmD, RPh, FIACP, FACA

Dr. Ken Speidel is well recognized for his broad experience in pharmacy practice and education with pharmacotherapeutic specialties in hormone therapy and pain management. Dr. Speidel is a leading subject-matter expert in pharmaceutical compounding with expertise in sterile and non-sterile compounding processes for the acute care, community, outpatient, and 503A/503B practice sectors. Dr. Speidel has played instrumental roles in the development of national standards for pharmacy compounding practices and provides consulting services to many organizations, including boards of pharmacy and hospital and health systems in the United States and abroad.

In addition to his worldwide consulting and educational work, Dr. Speidel is a retired Professor of Pharmacy Practice from the University of Findlay. Over the years, Dr. Speidel has assisted in the development and facilitation of many nationally recognized educational programs, approved by the Accreditation Council for Pharmacy Education (ACPE). Dr. Speidel served as senior surveyor and advisor for the development of the Pharmacy Compounding Accreditation Board (PCAB). Dr. Speidel has served as multi-term president of the National Home Infusion Association (NHIA), president of Hospice of Portage, and has been awarded fellowship status with the Alliance for Pharmacy Compounding (APC) and the American College of Apothecaries (ACA). Dr. Speidel received a Bachelor of Science and Doctor of Pharmacy from Ohio Northern University and has completed postdoctoral training in nutritional support and functional medicine.

Dr. Speidel is best known for his charismatic charm, his endless book of analogies, and ability to get everyone in the room motivated and passionate about personalized healthcare!